Risk stratification of patients with barrett's esophagus andlow-grade dysplasia or indefinite for dysplasia

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 3, 2015, Pages 459-465.e1

  Thota, Prashanthi N ^a   Lee, Hyun Ju ^a   Goldblum, John R ^a   Liu, Xiuli ^a   Sanaka, Madhusudhan R ^a   Gohel, Tushar ^a   Kanadiya, Mehulkumar ^a   Lopez, Rocio ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Carcinogenesis; Esophageal cancer; Patient management; Tumor

Indexed keywords

ADULT; ARGON PLASMA COAGULATION; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; CRYOTHERAPY; DISEASE COURSE; ENDOSCOPIC SURGERY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS DYSPLASIA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HIATUS HERNIA; HIGH GRADE DYSPLASIA; HUMAN; INCIDENCE; INDEFINITE FOR DYSPLASIA; LOW GRADE DYSPLASIA; MAJOR CLINICAL STUDY; MALE; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; SEX DIFFERENCE; ADENOCARCINOMA; AGED; COMPLICATION; ENDOSCOPY; ESOPHAGEAL NEOPLASMS; HYPERPLASIA; MIDDLE AGED; PATHOLOGY; PRECANCEROUS CONDITIONS; PROGNOSIS; RISK FACTOR;

ADENOCARCINOMA; ADULT; AGED; BARRETT ESOPHAGUS; DISEASE PROGRESSION; ENDOSCOPY; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 84925374781     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.07.049     Document Type: Article

References (38)

1. Howlader N., Noone A.M., Krapcho M., et al. SEER cancer statistics review, 1975-2010 2013, National Cancer Institute, Bethesda, MD.
2. Sharma P., Falk G.W., Weston A.P., et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006, 4:566-572.
3. Shaheen N.J., Crosby M.A., Bozymski E.M., et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus?. Gastroenterology 2000, 119:333-338.
4. de Jonge P.J., van Blankenstein M., Looman C.W., et al. Risk of malignant progression in patients with Barrett's oesophagus: Dutch nationwide cohort study. Gut 2010, 59:1030-1036.
5. Yousef F., Cardwell C., Cantwell M.M., et al. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: systematic review and meta-analysis. Am J Epidemiol 2008, 168:237-249.
6. Hvid-Jensen F., Pedersen L., Drewes A.M., et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. NEngl J Med 2011, 365:1375-1383.
7. Wani S., Falk G.W., Post J., et al. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus. Gastroenterology 2011, 141:1179-1186.
8. Curvers W.L., ten Kate F.J., Krishnadath K.K., et al. Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated. Am J Gastroenterol 2010, 105:1523-1530.
9. Dulai G.S., Shekelle P.G., Jensen D.M., et al. Dysplasia and risk of further neoplastic progression in regional Veterans Administration Barrett's cohort. Am J Gastroenterol 2005, 100:775-783.
10. Conio M., Blanchi S., Lapertosa G., et al. Long-term endoscopic surveillance of patients with Barrett's esophagus: incidence of dysplasia and adenocarcinoma-prospective study. Am J Gastroenterol 2003, 98:1931-1939.
11. Schnell T.G., Sontag S.J., Chejfec G., et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001, 120:1607-1619.
12. Srivastava A., Hornick J.L., Li X., et al. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol 2007, 102:483-493.
13. Lim C.H., Treanor D., Dixon M.F., et al. Low-grade dysplasia in Barrett's esophagus has high risk of progression. Endoscopy 2007, 39:581-587.
14. Rastogi A., Puli S., El-Serag H.B., et al. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: meta-analysis. Gastrointest Endosc 2008, 67:394-398.
15. Shaheen N.J., Sharma P., Overholt B.F., et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. NEngl J Med 2009, 360:2277-2288.
16. Spechler S.J., Sharma P., Souza R.F., et al. American Gastroenterological Association medical position statement on management of Barrett's esophagus. Gastroenterology 2011, 140:1084-1091.
17. Vieth M., Schubert B., Lang-Schwarz K., et al. Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: long-term histopathological follow-up study. Endoscopy 2006, 38:1201-1205.
18. Montgomery E., Bronner M.P., Goldblum J.R., et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001, 32:368-378.
19. Skacel M., Petras R.E., Gramlich T.L., et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol 2000, 95:3383-3387.
20. Skacel M., Petras R.E., Rybicki L.A., et al. p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression. Am J Gastroenterol 2002, 97:2508-2513.
21. Weston A.P., Banerjee S.K., Sharma P., et al. p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression. Am J Gastroenterol 2001, 96:1355-1362.
22. Kalbfleisch J.D., Prentice R.L. The statistical analysis of failure time data 1980, Wiley, New York.
23. Weston A.P., Sharma P., Mathur S., et al. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis. Am J Gastroenterol 2004, 99:1657-1666.
24. Conway J.M., Yanovski S.Z., Avila N.A., et al. Visceral adipose tissue differences in black and white women. Am J Clin Nutr 1995, 61:765-771.
25. Demerath E.W., Sun S.S., Rogers N., et al. Anatomical patterning of visceral adipose tissue: race, sex, and age variation. Obesity 2007, 15:2984-2993.
26. Hoffman D.J., Wang Z., Gallagher D., et al. Comparison of visceral adipose tissue mass in adult African Americans and whites. Obes Res 2005, 13:66-74.
27. Reid B.J., Blount P.L., Rubin C.E., et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992, 102:1212-1219.
28. Rossi M., Barreca M., de Bortoli N., et al. Efficacy of Nissen fundoplication versus medical therapy in regression of low-grade dysplasia in patients with Barrett esophagus: prospective study. Ann Surg 2006, 243:58-63.
29. Weston A.P., Krmpotich P.T., Cherian R., et al. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. Am J Gastroenterol 1997, 92:407-413.
30. Horwhat J.D., Baroni D., Maydonovitch C., et al. Normalization of intestinal metaplasia in the esophagus and esophagogastric junction: incidence and clinical data. Am J Gastroenterol 2007, 102:497-506.
31. Oelschlager B.K., Barreca M., Chang L., et al. Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery. Ann Surg 2003, 238:458-464.
32. Csendes A., Braghetto I., Burdiles P., et al. Late results of the surgical treatment of 125 patients with short-segment Barrett esophagus. Arch Surg 2009, 144:921-927.
33. Gurski R.R., Peters J.H., Hagen J.A., et al. Barrett's esophagus can and does regress after antireflux surgery: study of prevalence and predictive features. JAm Coll Surg 2003, 196:706-712.
34. Corley D.A., Kubo A., Levin T.R., et al. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: large community-based study, 1994-2006. Gut 2009, 58:182-188.
35. Connor M.J., Weston A.P., Mayo M.S. The prevalence of Barrett's esophagus and erosive esophagitis in patients undergoing upper endoscopy for dyspepsia in VA population. Dig Dis Sci 2004, 49:920-924.
36. Oberg S., Wenner J., Johansson J., et al. Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Ann Surg 2005, 242:49-54.
37. Guardino J.M., Khandwala F., Lopez R., et al. Barrett's esophagus at tertiary care center: association of age on incidence and prevalence of dysplasia and adenocarcinoma. Am J Gastroenterol 2006, 101:2187-2193.
38. Gonzalez S., Yu W.M., Smith M.S., et al. Randomized comparison of 3 different-sized biopsy forceps for quality of sampling in Barrett's esophagus. Gastrointest Endosc 2010, 72:935-940.